Change of Adviser

Allergy Therapeutics PLC
14 January 2008

14 January 2008



                            Allergy Therapeutics plc
                   ("Allergy Therapeutics" or "the Company")

                               Change of Adviser


Allergy Therapeutics is pleased to announce the appointment, with immediate
effect, of Nomura Code Securities Limited as Nominated Adviser to the Company.


For further information:

Allergy Therapeutics                                      [phone]
Keith Carter, Chief Executive

Nomura Code Securities                                    +44 (0)  207 776 1204
Juliet Thompson

Financial Dynamics                                        [phone]
Ben Brewerton






                      This information is provided by RNS
            The company news service from the London Stock Exchange